ÂÜÀòÂÒÂ×

George Appiah Kubi, PhD is a Scientist II at Entrada Therapeutics, where George synthesizes and purifies oligonucleotides and their conjugates. Prior to their current role, George held positions as a Postdoctoral Research Fellow at the National Institutes of Health and as a Graduate Research Associate at The Ohio State University, where George developed cell-penetrating peptides for cargo delivery. George also served as a Graduate Research Assistant and Graduate Teaching Associate at East Tennessee State University, focusing on surface functionalization and teaching chemistry laboratories. Their background includes a PhD in Organic Chemistry, a Master's degree in Chemistry, and a Bachelor's degree in Chemistry.